Idarubicin hydrochloride and Cystitis aggravated - a phase IV clinical study of FDA data

Summary:

Cystitis aggravated is found among people who take Idarubicin hydrochloride, especially for people who are male, 10-19 old, have been taking the drug for 6 - 12 months.

The phase IV clinical study analyzes which people take Idarubicin hydrochloride and have Cystitis aggravated. It is created by eHealthMe based on reports of 766 people who have side effects when taking Idarubicin hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 06, 2022

766 people reported to have side effects when taking Idarubicin hydrochloride.
Among them, 14 people (1.83%) have Cystitis aggravated.


What is Idarubicin hydrochloride?

Idarubicin hydrochloride has active ingredients of idarubicin hydrochloride. eHealthMe is studying from 769 Idarubicin hydrochloride users for its effectiveness, alternative drugs and more.

What is Cystitis aggravated?

Cystitis aggravated (worse inflammation of the wall of the bladder) is found to be associated with 1,174 drugs and 500 conditions by eHealthMe.

Number of Idarubicin hydrochloride and Cystitis aggravated reports submitted per year:

Could Idarubicin hydrochloride cause Cystitis aggravated?

Time on Idarubicin hydrochloride when people have Cystitis aggravated *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Cystitis aggravated when taking Idarubicin hydrochloride *:

  • female: 23.08 %
  • male: 76.92 %

Age of people who have Cystitis aggravated when taking Idarubicin hydrochloride *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 63.64 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 36.36 %

Common drugs people take besides Idarubicin hydrochloride *:

  1. Fludara: 5 people, 35.71%
  2. Cytarabine: 4 people, 28.57%
  3. Dasatinib: 3 people, 21.43%
  4. Zolpidem: 2 people, 14.29%
  5. Prozac: 2 people, 14.29%
  6. Vesanoid: 1 person, 7.14%
  7. Rydapt: 1 person, 7.14%
  8. Prednisone: 1 person, 7.14%
  9. Dexamethasone Acetate: 1 person, 7.14%
  10. Chlorhexidine Gluconate: 1 person, 7.14%

Common side effects people have besides Cystitis aggravated *:

  1. Pneumonia: 7 people, 50.00%
  2. Pleural Effusion (water on the lungs): 7 people, 50.00%
  3. Hyperpyrexia (extremely high fever): 3 people, 21.43%
  4. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 21.43%
  5. High Blood Pressure: 3 people, 21.43%
  6. Febrile Neutropenia (fever with reduced white blood cells): 2 people, 14.29%
  7. Febrile Bone Marrow Aplasia (bone marrow greatly decreases or stops production of blood cells): 2 people, 14.29%
  8. Electrocardiogram Qt Prolonged: 1 person, 7.14%
  9. Hepatic Failure (liver failure): 1 person, 7.14%
  10. Headache (pain in head): 1 person, 7.14%

Common conditions people have *:

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 7 people, 50.00%
  2. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 28.57%
  3. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 14.29%
  4. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 14.29%
  5. Acute Promyelocytic Leukaemia (cancer of the blood and bone marrow): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Idarubicin hydrochloride and have Cystitis aggravated?

Check whether Cystitis aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Cystitis aggravated and when was it recovered:

Expand to all the drugs that have ingredients of idarubicin hydrochloride:

Alternative drugs to, pros and cons of Idarubicin hydrochloride:

Cystitis aggravated treatments and more:

COVID vaccines that are related to Cystitis aggravated:

Common drugs associated with Cystitis aggravated:

All the drugs that are associated with Cystitis aggravated:

Common conditions associated with Cystitis aggravated:

All the conditions that are associated with Cystitis aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on idarubicin hydrochloride (the active ingredients of Idarubicin hydrochloride) and Idarubicin hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: